Litcius/Paper detail

AB0222 COMPARISON OF SELF-INJECTION DEVICES FOR ADMINISTERING ANTI-TUMOR NECROSIS FACTOR AGENTS USING THE ORIGINAL QUESTIONNAIRE IN PATIENTS WITH RHEUMATOID ARTHRITIS

Y. Hirano, Junichi Hasegawa

2021Annals of the Rheumatic Diseases31 citationsDOI

Topics & Concepts

MedicineRheumatoid arthritisGolimumabAdalimumabEtanerceptCertolizumab pegolSyringeInternal medicineInfliximabTumor necrosis factor alphaSurgeryPharmacologyPsychiatryRheumatoid Arthritis Research and TherapiesMonoclonal and Polyclonal Antibodies ResearchPeripheral Neuropathies and Disorders
AB0222 COMPARISON OF SELF-INJECTION DEVICES FOR ADMINISTERING ANTI-TUMOR NECROSIS FACTOR AGENTS USING THE ORIGINAL QUESTIONNAIRE IN PATIENTS WITH RHEUMATOID ARTHRITIS | Litcius